AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan · Delayed Price · Currency is TWD 58.30
+0.10 (0.17%)
May 29, 2026, 1:51 PM CST
AnnJi Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -357.87 | -353.99 | -329.22 | -236.65 | -198.63 |
Depreciation & Amortization | 44.2 | 44.3 | 37.74 | 40.05 | 41.51 |
Other Amortization | 0.96 | 0.65 | 0.55 | 0.38 | 0.12 |
Loss (Gain) From Sale of Assets | - | -0.09 | -0.2 | -0.34 | - |
Loss (Gain) From Sale of Investments | 0.97 | 4.54 | 29.42 | - | - |
Stock-Based Compensation | 8.08 | 46.78 | 48.2 | 6.66 | 3.02 |
Other Operating Activities | -1.99 | -0.47 | 38.92 | - | -0.01 |
Change in Accounts Receivable | 0.01 | -0.15 | 0.09 | -0.09 | - |
Change in Inventory | 9.31 | -27.42 | - | - | - |
Change in Accounts Payable | -0.12 | 0.12 | - | 15.66 | 4.39 |
Change in Unearned Revenue | -6.38 | 66.65 | 89.56 | 1.6 | - |
Change in Other Net Operating Assets | -47.46 | 33.06 | 17.73 | -16.75 | 9.21 |
Operating Cash Flow | -350.29 | -186.01 | -67.2 | -189.49 | -140.39 |
Capital Expenditures | -2.91 | -9.95 | -12.04 | -1.58 | -3.23 |
Sale of Property, Plant & Equipment | - | 0.09 | 0.26 | 0.36 | - |
Sale (Purchase) of Intangibles | -0.82 | -0.56 | -0.35 | -0.42 | -0.52 |
Investment in Securities | 74 | 198 | -274 | - | 100 |
Other Investing Activities | -0.03 | 0.74 | -1.9 | - | 0.39 |
Investing Cash Flow | 70.23 | 188.31 | -288.02 | -1.65 | 96.65 |
Short-Term Debt Repaid | - | - | - | - | -17.08 |
Long-Term Debt Repaid | -5.98 | -5.95 | - | -2.79 | -3.25 |
Total Debt Repaid | -5.98 | -5.95 | - | -2.79 | -20.33 |
Net Debt Issued (Repaid) | -5.98 | -5.95 | - | -2.79 | -20.33 |
Issuance of Common Stock | 3.46 | 33.02 | 685.18 | 70 | 364.5 |
Other Financing Activities | - | 1.82 | - | -0.16 | - |
Financing Cash Flow | -2.52 | 28.89 | 685.18 | 67.05 | 344.17 |
Foreign Exchange Rate Adjustments | - | - | - | 0.57 | -0.57 |
Net Cash Flow | -282.57 | 31.19 | 329.96 | -123.51 | 299.85 |
Free Cash Flow | -353.2 | -195.97 | -79.23 | -191.07 | -143.62 |
Free Cash Flow Margin | -4676.88% | -203.18% | -55.20% | -11750.92% | -10008.22% |
Free Cash Flow Per Share | -3.76 | -2.11 | -1.02 | -2.91 | -3.18 |
Cash Interest Paid | 1.6 | 2.25 | - | 0.03 | 0.15 |
Cash Income Tax Paid | - | - | -0.01 | 1.59 | -0.01 |
Levered Free Cash Flow | -353.92 | -78.57 | 93.18 | -104.84 | - |
Unlevered Free Cash Flow | -352.92 | -77.46 | 93.47 | -104.82 | - |
Change in Working Capital | -44.63 | 72.26 | 107.38 | 0.42 | 13.6 |